Impaired Redox and Protein Hemeostasis as Risk Factors and Therapeutic Targets in Toxin-Induced Biliary Atresia Wednesday, September 9, 2020 Read more
Gene Expression Signatures Associated with Survival Times of Pediatric Patients with Biliary Atresia Identify Potential Therapeutic Agents Thursday, October 10, 2019 Read more
Serum proteomics uncovers biomarkers of portal hypertension in children with biliary atresia Thursday, May 5, 2022 Read more
Deleterious Variants in ABCC12 are Detected in Idiopathic Chronic Cholestasis and Cause Intrahepatic Bile Duct Loss in Model Organisms Wednesday, July 14, 2021 Read more
TWEAK/FN14 promotes profibrogenic pathway activation in Prominin-1-expressing hepatic progenitor cells in biliary atresia Tuesday, January 3, 2023 Read more
Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States Generic medications reduce the lifetime costs of organ transplantation Wednesday, March 6, 2019 The priceless gift of a transplanted organ comes with life-long costs of the critical immunosuppressant medications that prevent rejection. Although Medicare provides coverage for these drugs to kidney transplant recipients in the three years following a transplant, many transplant recipients have difficulty affording the related out-of-pocket costs post-transplantation. Findings of a study conducted by Arbor Research Collaborative for Health indicate the potential of relief for these patients and Medicare. This work by Margaret E. Helmuth and her colleagues was published February 28, 2019, in the Clinical Journal of the American Society of Nephrology (CJASN). They examined cost changes following the introduction of generic variations of two commonly prescribed immunosuppressants and determined that the introduction of generic medications in this class has resulted in substantial savings for transplant patients and Medicare. Read more
Study of self-reported symptom clusters may improve the diagnosis and treatment of women with lower urinary tract disorders Study of self-reported symptom clusters may improve the diagnosis and treatment of women with lower urinary tract disorders Wednesday, August 8, 2018 Currently, women with lower urinary tract symptoms (LUTS) are treated according to their most troubling symptom. This approach is not always completely successful, as it does not take into account that patients can have multiple symptoms that respond to different treatments. Read more
Neurodevelopment in young children with biliary atresia Neurodevelopment in young children with biliary atresia Tuesday, May 1, 2018 Infancy and early childhood is a time of critical neurodevelopment. It is also an important time for monitoring that development, particularly in children with chronic illnesses. Read more
Uptake of Generic vs Brand Name Immunosuppressants Among US Organ Transplant Recipients Uptake of Generic vs Brand Name Immunosuppressants Among US Organ Transplant Recipients Wednesday, July 18, 2018 After an organ transplant, a transplant recipient must take immunosuppressive medications to reduce the risk of their body rejecting the transplanted organ. Although using therapeutically equivalent generic medications can reduce financial burden, the transplant community has expressed caution about substituting these for brand-name immunosuppressants. Read more
DOPPS Program Spring Scientific Update Meeting via webinar on Friday, June 9th from 8am – 11am Wednesday, May 31, 2023
Arbor Research Collaborative for Health Welcomes New Vice President (VP) of Research, Dr. Cori Sheedy Thursday, April 6, 2023
Arbor Research Collaborative for Health Welcomes Research Scientist, Dr. Christine Stanik Wednesday, February 15, 2023
Arbor Research Awarded a $1.5M Contract to Support AHRQ in Developing their Patient-Centered Outcomes Research Trust Fund (PCORTF) Strategic Plan Thursday, December 8, 2022
Arbor Research Collaborative for Health Awarded $1.2 Million Contract from CDC to Help Nursing Homes Use Electronic Health Records to Report Healthcare Acquired Infections Thursday, October 20, 2022
Arbor Research Collaborative for Health to Serve on Team Evaluating the End-Stage Renal Disease Treatment Choices Model and the Kidney Care Choices Model Friday, September 16, 2022
Arbor Research Collaborative for Health Announces Partnership with Altarum to Support and Evaluate the National Hypertension Control Initiative Tuesday, April 26, 2022
Arbor Research Collaborative for Health Announces Hire of Chauncey Lynch, BS, as Vice President of Finance & Chief Financial Officer Monday, March 28, 2022
PDOPPS: International Icodextrin Use and Association with Peritoneal Membrane Function, Fluid Removal, Patient and Technique Survival Friday, March 18, 2022
Arbor Research Collaborative for Health Announces Hire of Shanthy Edward, M.A., Psy.D. as Vice President of Strategic Growth & Chief Growth Officer Monday, March 7, 2022